Opana ER is a brand name for the extended-release formulation of the opioid pain medication oxymorphone hydrochloride. It is classified as a Schedule II controlled substance due to its high potential for abuse and addiction. Opana ER is primarily prescribed for the management of chronic pain when continuous, around-the-clock opioid therapy is needed for an extended period.